Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis

Neuropharmacology

Volumn 85, Issue , 2014, Pages 158-165

  Gaberel, Thomas ^a,b   Montagne, Axel ^b   Lesept, Flavie ^b   Gauberti, Maxime ^b   Lemarchand, Eloïse ^b   Orset, Cyrille ^b   Goulay, Romain ^b   Bertrand, Thomas ^b   Emery, Evelyne ^a,b   Vivien, Denis ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Animal model; Cerebral hemorrhage; Fibrinolytic agents; Intraventricular; Tissue type plasminogen activator; Urokinase type plasminogen activator; Ventriculostomy

Indexed keywords

ALTEPLASE; UROKINASE; COLLAGENASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN SIZE; BRAIN VENTRICLE DILATATION; BRAIN WATER; CEREBROSPINAL FLUID DRAINAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; EXCITOTOXICITY; FIBRINOLYSIS; IN VITRO STUDY; INFLAMMATION; MALE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CELL CULTURE; CEREBRAL HEMORRHAGE; COMPARATIVE STUDY; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; HEMATOMA; HYDROCEPHALUS; IMMUNOMODULATION; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; BRAIN EDEMA; CELLS, CULTURED; CEREBRAL HEMORRHAGE; COLLAGENASES; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEMATOMA; HYDROCEPHALUS; MALE; MICE; NEUROIMMUNOMODULATION; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84902277468     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.001     Document Type: Article

References (29)

1. E. Cho, K.J. Lee, J.W. Seo, C.J. Byun, S.J. Chung, and D.C. Suh et al. Neuroprotection by urokinase plasminogen activator in the hippocampus Neurobiol. Dis. 46 2012 215 224
2. M.N. Diringer, D.F. Edwards, and A.R. Zazulia Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage Stroke 29 1998 1352 1357
3. A.F. Ducruet, Z.L. Hickman, B.E. Zacharia, B.T. Grobelny, R. Narula, and K.H. Guo et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage Neurosurgery 66 2010 648 655
4. T. Gaberel, C. Magheru, and E. Emery Management of non-traumatic intraventricular hemorrhage Neurosurg. Rev. 35 2012 485 494
5. T. Gaberel, C. Magheru, J.J. Parienti, H.B. Huttner, D. Vivien, and E. Emery Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis Stroke 42 2011 2776 2781
6. T. Gaberel, R. Macrez, M. Gauberti, A. Montagne, M. Hebert, and K.U. Petersen et al. Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome Neuropharmacology 67 2013 267 271
7. D.F. Hanley Intraventricular hemorrhage and ICH outcomes: severity factor and treatment target Stroke 40 2009 1533 1538 Review
8. R.F. Keep, Y. Hua, and G. Xi Intracerebral haemorrhage: mechanisms of injury and therapeutic targets Lancet Neurol. 11 2012 720 731
9. K.R. Lohdia, P. Shakui, and R.F. Keep Hydrocephalus in a rat model of intraventricular hemorrhage Acta Neurochir. Suppl. 96 2006 207 211
10. J.P. Lopez-Atalaya, B.D. Roussel, D. Levrat, J. Parcq, O. Nicole, and Y. Hommet et al. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity J. Cereb. Blood Flow Metab. 28 2008 1212 1221
11. H.P. Mattle, and A. Raabe CLEAR intraventricular hemorrhage: more than a glimmer of hope Stroke 42 2011 2999 3000
12. L. Mayfrank, J. Kissler, R. Raoofi, P. Desling, J. Weis, and W. Kuker et al. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment Stroke 28 1997 141 148
13. L. Mayfrank, Y. Kim, J. Kissler, P. Desling, J.M. Gisbach, and J.M. Schroder et al. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator Acta Neuropathol. 100 2000 561 567
14. A. Montagne, M. Hébert, A. Jullienne, F. Lesept, A. Le Behot, and M. Louessard et al. Memantine improves safety of thrombolysis for stroke Stroke 43 2012 2774 2781
15. T. Morgan, I. Awad, and P. Keyl et al. Preliminary report of the clot lysing accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial Acta Neurochir. Suppl. 105 2008 217 220
16. O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet, and E.T. MacKenzie et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
17. D.J. Nieuwkamp, K. de Gans, G.J. Rinkel, and A. Algra Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature J. Neurol. 247 2000 117 121
18. V. Novokhatny, L. Medved, A. Mazar, P. Marcotte, J. Henkin, and K. Ingham Domain structure and interactions of recombinant urokinase-type plasminogen activator J. Biol. Chem. 267 1992 3878 3886
19. D. Pang, R.J. Sclabassi, and J.A. Horton Lysis of intraventricular blood clot with urokinase in a canine model, part 1: canine intraventricular blood cast model Neurosurgery 19 1986 540 546
20. D. Pang, R.J. Sclabassi, and J.A. Horton Lysis of intraventricular blood clot with urokinase in a canine model, part 2: in vivo safety study of intraventricular urokinase Neurosurgery 19 1986 547 552
21. D. Pang, R.J. Sclabassi, and J.A. Horton Lysis of intraventricular blood clot with urokinase in a canine model, part 3: effects of intraventricularurokinase on clot lysis and posthemorrhagic hydrocephalus Neurosurgery 19 1986 553 572
22. A.I. Qureshi, A.D. Mendelow, and D.F. Hanley Intracerebral haemorrhage Lancet 373 2009 1632 1644 Review
23. G.A. Rosenberg, S. Mun-Bryce, M. Wesley, and M. Kornfeld Collagenase-induced intracerebral hemorrhage in rats Stroke 21 1990 801 807
24. E. Tejima, B.Q. Zhao, K. Tsuji, A. Rosell, K. van Leyen, and R.G. Gonzalez et al. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage J. Cereb. Blood Flow Metab. 27 2007 460 468
25. R. Thiex, J. Weis, T. Krings, S. Barreiro, F. Yakisikli-Alemi, and J.M. Gilsbach et al. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages J. Neurosurg. 106 2007 314 320
26. S. Tuhrim, D.R. Horowitz, M. Sacher, and J.H. Godbold Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage Crit. Care Med. 27 1999 617 621
27. B. Volbers, I. Wagner, W. Willfarth, A. Doerfler, S. Schwab, and D. Staykov Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage Stroke 44 2013 362 366
28. Y.C. Wang, C.W. Lin, C.C. Shen, S.C. Lai, and J.S. Kuo Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship J. Neurol. Sci. 202 2002 35 41
29. W. Ziai, T. Moullaali, S. Nekoovaght-Tak, N. Ullman, J.S. Brooks, and T.C. Morgan et al. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage Neurocrit. Care 18 2013 354 361